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Background: Toll-like receptor 2 (TLR2) is important to host recognition of invading gram-positive microbes. In
goats, these microbes can cause serious mastitis, anthrax, tetanus, and other problems. Transgenic goats
constitutively over-expressing TLR2 in many tissues serve as a suitable model for the study of the role of TLR2
over-expression in bacterial clearance.
Results: Capra hircus TLR2 over-expression vector (p3S-LoxP-TLR2) was used to generate transgenic goats by egg
microinjection. The integration efficiency was 8.57%. Real-time PCR and immunohistochemical results confirmed
that the goats over-expressing the TLR2 gene (Tg) expressed more TLR2 than wild-type goats (WT).
Monocyte-macrophages from the bloodstreams of transgenic goats were stimulated with synthetic bacterial
lipoprotein (Pam3CSK4) and by the promotion of interleukin-6 (IL-6) and IL-10 expression in vitro. The oxidative
damage was significantly reduced, and lysozyme (LZM) secretion was found to be up-regulated. Ear tissue samples
from transgenic goats that had been stimulated with Pam3CSK4 via hypodermic injection showed that transgenic
individuals can undergo the inflammation response very quickly.
Conclusions: Over-expression of TLR2 was found to decrease radical damage to host cells through low-level
production of NO and MDA and to promote the clearance of invasive bacteria by up-regulating lysozyme secretion
and filtration of inflammatory cells to the infected site.
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Most gram-positive bacteria, such as Bacillus anthracis, M.
tuberculosis, Staphylococcus aureus, and Clostridiumtetani,
are harmful. They cause a wide range of diseases in
both immunocompetent and immunocompromized
hosts. Many of them can cause serious health problems
in goats. These include mastitis, erysipelas, listeriosis,* Correspondence: popo84350746@126.com
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reproduction in any medium, provided the oranthrax, encephalitis, and spontaneous abortion. Toll-like
receptors (TLRs) are type I trans-membrane proteins.
They are ligands of a large number of endogenous and ex-
ogenous targets. TLR2 is considered the main pattern
receptor of various gram-positive bacteria—including
mycobacteria, viruses, and their products [1]. TLR2 can
form heterodimers with both TLR1 and TLR6. These
heterodimers play a key role in innate immunity by bind-
ing pathogen-associated molecular patterns (PAMP) and
causing an inflammatory cascade reaction [2]. This acti-
vates monocytes and macrophages and promotes neutro-
phil infiltration [3]. The signalling pathway initiated
by TLR2 is called the myeloid-differentiation-factor88-
dependent pathway (MyD88-dependent pathway) [4,5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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but not all of them show the same levels of expression [6].
Under challenge, TLR2 expression is up-regulated. This
results in translocation of nuclear factor (NF-κB), which in
turn causes the production of pro-inflammatory cytokines,
such as interleukin-6 (IL-6) and nitric oxide (NO). Studies
have shown that TLR2 acts as an agonist by modulating
the immune response and Th1/Th2 balance [7]. IL-6 is a
pro-inflammatory cytokine. It is produced by Th2 cells
and acts as a mediator of acute phase response. It acceler-
ates the infiltration of inflammatory cells. Cytokines such
as IFN-γ, which is produced by Th1 cells, inhibit the dif-
ferentiation of Th2 cells. IL-10, an immune regulation
cytokine produced by monocytes and macrophages, is cru-
cial to Th1/Th2 balance [8]. Several types of immune dys-
function can occur if this balance is disrupted. During
pathogen infection, a healthy Th1/Th2 balance can facili-
tate an effective host response. Lysozyme (LZM) is espe-
cially active against gram-positive bacteria. Lysozyme
breaks down the carbohydrate chains on their surfaces,
destroying the structural integrity of the cell wall. The bac-
teria then burst under their own internal pressure.
Synthetic bacterial lipopeptide Pam3CSK4 is a TLR2
agonist. It is a heterodimer of TLR1 and TLR2 [9]. TLR2
serves as the recognizing receptor for gram-positive bac-
teria. Study showed TLR2 expression up-regulated under
Pam3CSK4 challenge.
To determine the effect of over-expression of TLR2 on
pathogen resistance, TLR2 transgenic goats were gener-
ated. Pam3CSK4 was used as a TLR2 activator. NO,
MDA, and LZM products were detected and used to
evaluate the immune response. Further experiments
were performed out to determine the effects of over-
expression of TLR2 on the immune systems of goats
both in vivo and in vitro. Tissue sections were evaluated
histological. The blood biochemical parameters of the
experimental goats were characterized.
Results
Production of transgenic goats over-expressing Capra
hircusTLR2
Capra hircus TLR2 cDNA was generated using RT-PCR.
A 2365 bp fragment was amplified. This fragment was
linked to double-enzyme-digested p3S-LoxP vector. Two
LoxP sequences were introduced. An expression vector,
p3S-LoxP-TLR2, was constructed (Figure 1A). As shown
in Table 1, 5 pL of linearized plasmid was microinjected
into 221 embryos in total, and these injected embryos
were immediately transferred into 40 recipients, produ-
cing 35 goats. Southern blot analysis confirmed that 3 of
these goats were transgenic. The dose of 5 ng/μL was
found to be more efficient than 10 ng/μL (Table 1 and
Figure 1B). Real-time PCR analysis was performed to
determine levels of TLR2 transcription. During theexperiment, TLR2 expression in Tg goats was higher
than in control goats (Figure 1C). The amount of TLR2
mRNA in transgenic goats (Tg) was significantly higher
than in wild-type goats (WT) at 0.5, 2, and 48 hours
(P<0.05). In Tg, TLR2 transcription reached its peak 2
hours after challenge. Immunohistochemical results con-
firmed that the Tg group expressed more TLR2 than the
WT group (Figure 1D).Normal blood biochemical parameters of transgenic
goats
There was no statistically significant difference between
transgenic goats and non-transgenic goats with respect
to routine blood and serum biochemical parameters at
120 days (Tables 2 and 3).Promotion of IL-6 and IL-10 expression in transgenic
goats
Under Pam3CSK4 stimulation, levels of secreted IFN-γ
were significantly lower in the Tg group than in the WT
group at 0.5 hours. During the experiment, IFN-γ ex-
pression was unregulated in Tg, and this pattern
remained relatively stable. Peak IFN-γ expression was
observed at 8 hours post stimulation in Tg, which is
earlier than in the WT group. The expression of IFN-γ
in the WT group showed a fluctuating uptrend, includ-
ing two points of up-regulation. The peak concentration
of the WT group was observed 24 hours after stimula-
tion. It was also higher than the peak concentration
observed in the Tg group. At 8 hours, IL-6 levels were
higher in the Tg group than in the WT group (P<0.05).
This may have caused an acute inflammatory response.
In the Tg group, IL-10 expression reached its highest
level at 24 hours and then became down-regulated
(Figure 2A, B, and C).
In the WT group, IFN-γ levels increased during the
first 0.5 hours, but IL-10 expression was up-regulated
immediately. High levels of IFN-γ expression were
observed 24 hours after challenge. In contrast, IL-10
and IL-6 expression decreased, and minimal levels of
IL-6 were observed. Soon after that, IL-10 expression
increased again. This indicates that the inflammatory
response was being suppressed.
In the Tg group, there was an inflammatory imbal-
ance between IL-10 and IL-6 when IL-6 and IFN-γ
levels peaked at 8 hours and subsequently decreased.
This suggests that a strong inflammatory reaction oc-
curred. The highest IL-10 level was detected at 24
hours. This indicates that the inflammatory reaction
was inhibited. These results suggest that over-
expression of TLR2 might regulate the expression of
Th2 cytokines and trigger the inflammatory response.
Figure 1 Transgenic goats over-expressing Capra hircus TLR2. (A) Structure of p3S-LoxP-TLR2 plasmids. (B) Southern blotting analysis, 1–3:
positive samples; 4–7: negative samples; 8: control; 9, 10: p3S-Loxp-TLR2 plasmid. (C) Relative quantitative analysis of TLR2 mRNA expression
under Pam3CSK4 stimulation. (D) Immunohistochemical study of TLR2 protein product: transgenic (Tg) group, wild-type (WT) group. Sections
were double-stained with DAPI (blue) and TLR2-FITC (green).
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In the immune response, NO acts as a functional cel-
lular signalling molecule. In macrophages, nitric
oxide synthase (NOS) is positively regulated by IFN-
γ. MDA is one of the most frequently used indicators
of lipid per-oxidation. In this study, the concentra-
tions of NO and MDA in the WT group were higher
than in the Tg group at 0.5 hours and 2 hours
(P<0.05), and they remained relatively low and stable
in the Tg group (Figure 2D and E).Table 1 Microinjection production of over-expression of
















5 ng/μL 8 99 19 10 10.00 (1/10)
10 ng/μL 10 122 21 25 8.00 (2/25)
Total 18 221 40 35 8.57 (3/35)
Note: No. =number.Up-regulation of lysozyme secretion in transgenic goats
Lysozymes are small enzymes that attack the protective
cell walls of bacteria. Lysozymes break carbohydrate
chains, destroying the structural integrity of the cell wall.
LZM expression in the Tg group was higher than in the
WT group at 0.5 hours (P<0.05), after which it showed a
steady upward trend (Figure 2F).
Rapid filtration of inflammatory cells in transgenic goats
Goats were intradermally injected with Pam3CSK4 in
the ear. Red blood cell infiltration was observed in bothTable 2 Routine blood examinations of wild-type and
TLR2 transgenic goats
Blood routine Tg WT
WBC (109/L) 14.59±2.7 19.91±7.33
RBC (1012/L) 4.13±0.52 4.01±0.26
HGB (g/L) 102.67±7.0 108±3.61
HCT (%) 13.83±1.72 13.57±0.85
Table 3 Blood biochemistry of wild-type and TLR2
transgenic goats
Blood biochemistry Tg WT
TP (g/L) 69.07±11.45 73.27±12.78
Alb (g/L) 24.1±2.55 25.3±0.95
Glo (g/L) 45.3±9.29 47.97±12.92
ALT (μ/L) 39±15.39 45.33±6.03
AST (μ/L) 88.33±21.78 94.33±9.5
CRP (mg/L) 1.81±0.42 1.72±0.31
BUN (mmol/L) 6.67±2.16 7.88±0.44
Glu (mmol/L) 4.51±0.18 3.77±0.65
TG (mmol/L) 0.38±0.19 0.42±0.16
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hours after Pam3CSK4 challenge. Eight hours after
Pam3CSK4 challenge, dermal damage was assessed and
serious red cell and inflammatory cell infiltration was
observed in the WT group. However, no pathological
changes were observed in the Tg group 8 hours after
treatment with Pam3CSK4 (Figure 3).
Discussion
TLR2 is as a key player in the defence against organ dam-
age and in innate immunity. It provides an important linkFigure 2 Transgenic goats over-expressing Capra hircus TLR2 monocy
IL-6 and IL-10 expression in transgenic goats, ELISA testing of changes in in
Prevention oxidative damage in transgenic goats, levels of NO and MDA ex
by ELISA. Data are means ± SE. * Values within the same concentration of
different groups at different times (P<0.05). Tg = transgenic group, WT = wbetween innate and adaptive immunity [10]. During bac-
terial infection, viral infection, host defence, allergic
response, and transplant rejection, the Th1/Th2 cytokine
balance is broken. The functional polymorphisms of TLR2
have been reported [11]. By binding with its ligand, TLR2
causes the activation of NF-κB, ultimately leading to the
transcription of cytokines, chemokines, and co-stimula-
tors. Once TLR2 is activated, TLR2-mediated Th2
responses are induced [12,13]. Studies have shown that
the TLR2 pathway directly triggers the production of Th1
cytokines [14,15]. It has been reported that Th1 cytokines
tend to induce pro-inflammatory responses and Th2-
related cytokines, including IL-6 and IL-10, tend to pro-
duce anti-inflammatory responses and can counteract the
Th1-mediated microbicidal actions [16]. In launching
complex inflammatory reactions, IL-6 plays a crucial role
as a pro-inflammatory cytokine. High levels of IL-6 can ac-
tivate monocytes and macrophages [17]. IL-10 is the main
anti-inflammatory factor [18].
During the onset of immune response, pro-inflammatory
cytokines like IL-6 play a dominant role. During later
phases, anti-inflammatory cytokine expression increases to
prevent immune overreaction [19]. IFN-γ can inhibit Th2
cells and IL-10 can decrease levels of Th1-related cytokines,
preventing the generation of monocyte-derived DCs [20].
Changes in IL-10, IL-6, and IFN-γ levels reflect thetes and macrophages under Pam3CSK4 stimulation. Promotion of
flammatory cytokines: (A) IFN-γ, (B) IL-6, and (C) IL-10 expression.(D, E)
pression. (F) Up-regulation of lysozyme secretion in transgenic goats
Pam3CSK4 (1 μg/mL) were found to differ significantly between
ild-type group.
Figure 3 Goats intradermally injected with 1 mg Pam3CSK4 in the ear. Rapid filtration of inflammatory cells in transgenic goats. Pathologic
changes were examined microscopically (×400). Tg = transgenic group, WT = wild-type group.
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rium and immune function [21]. IFN-γ and IL-10 expres-
sion was found to be up-regulated earlier in the Tg group
than in the WT group. As a consequence, levels of pro-
inflammatory cytokine decreased to their original values
faster in the Tg group than in the WT group. Our results
indicate that Pam3CSK4 stimulation might cause immuno-
suppression in the WT group. TLR2 transcription levels
were found to be positively correlated with IL-10, IL-6, and
IFN-γ levels in the Tg group. They were able to promote
immune response. A slight up-regulation of IL-10 was
observed at 0.5 hours post challenge. One reasonable ex-
planation for this might be was negative self-regulation of
the immune system. This regulation would reduce the in-
tensity of cascade immune reactions, prevent monocyte-
and macrophage-induced damage, and decrease the effects
of the inflammatory responses that cause tissue damage.
Recent studies have revealed that TLR2−/− mice experi-
enced strong immune reactions [22]. Up-regulated expres-
sion of TLR2 in multiple organs was found to have a high
mortality rate [23]. TLR2 was also found to induce neutro-
phil activation [24]. In the Tg group, Pam3CSK4-induced
cytokine imbalances were resolved, and cytokine levels
returned to original levels within 48 hours. This was earlier
than in the WT group. Tissue sections showed that neutro-
phil activation enhanced rapid infiltration in Tg animals.
Tissue damage attributable to severe inflammatory reaction
was found to be inhibited by TLR2 over-expression.NO is produced by a variety of cells. It has many func-
tions involved in the response to microbe invasion and
inflammatory injury. During macrophage activation,
large amounts of NOS and super oxide anion radicals
are released alongside NO and H2O2. The toxic effects
of NO on nearby tissue and of NOS production on cells
have been reported. Studies have found that the damage
to cellular proteins, lipids, and nucleic acids caused by
oxidation can contribute to immune reactions involving
TLR2 [25]. One previous study indicated that activation
of NF-κB was remarkably enhanced by exposed to NO
in RAW264.7 cells [26]. The relatively low levels of NO
were able to trigger downstream pathways and keep the
defence mechanism functioning properly. In contrast,
the activation of NF-κB was inhibited by high concentra-
tions of NO [27]. The suppression of NF-κB activation
decreased the inflammatory response and prevented tis-
sue damage. Our results indicate that TLR2 over-
expression was correlated to stable NO and MDA levels
and moderate levels of oxidative stress. Recent reports
have shown that lysozyme promotes the release of TLR2
stimulants from gram-positive organisms [28]. The
results of the present study indicate that monocyte-
macrophages were activated by Pam3CSK4 and that
lysozyme secretion increased. Lysozyme content was
higher in the Tg group than in the WT group. TLR2
over-expression was found to up-regulate lysozyme
secretion and it may contribute to bacterial clearance.
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Goats over-expressing Capra hircus TLR2 were not
found to differ significantly from wild-type goats in any
physiological or biochemical respect. Among Tg animals,
IL-6 levels were up-regulated and IFN-γ-induced im-
munity was depressed. NO concentrations remained
relatively low. Enhancement of IL-10 expression oc-
curred earlier than in wild-type. Inflammatory infiltra-
tions and lysozyme secretion were increased. In vivo
study indicated that the immune system responded
quickly to protect tissue from damage. All of these
results indicate that tissue damage can be prevented by
over-expression of TLR2. This information may be use-
ful to fostering disease resistance in goat breeding.
Methods
Animals
Superovulation, artificial insemination, intradermic in-
jection, and blood collection were performed at the ex-
perimental station of the China Agricultural University.
The study was carried out in strict accordance with the
protocol approved by the Animal Welfare Committee of
China Agricultural University (Permit Number: XK662).
Production of Capra hircusin goats over-expressing TLR2
Total RNA was extracted from goat spleens using an
RNA kit (OMEGABio-Tek, Doraville, GA, U.S.). cDNA
was synthesized using M-MLV reverse transcriptase
(Promega, Madison, WI, U.S.) in accordance with the
manufacturer’s instructions and following the Capra
hircus TLR2 gene sequence (GenBank: GU984768.1).
The eukaryotic expression vector pN1 (Plasmid12193;
Addgene, Cambridge, MA, U.S.) was used as a backbone
for the transformation. It was generated by removal of
the EGFP gene from pEGFP-N1. The construct sub-
cloned from pIRES2-EGFP (Plasmid12193; Addgene,
Cambridge, MA, U.S.) contained an IRES-EGFP frag-
ment connected to pN1 after introduction of a LoxP se-
quence on either side. This expression vector is called
p3S-LoxP. Both the Capra hircus TLR2 sequence and
p3S-LoxP were digested before ligation. The new expres-
sion vector is here called p3S-LoxP-TLR2.
Healthy laso-shan dairy goats were put into synchro-
nized estrus using CIDR (Pharmacia & UpjohnCompany,
Rydalmere, Australia). Ova were collected from donors
using superovulation. Zygotes were generated using
in vitro fertilization. The zygotes were microinjected
with linearized p3S-LoxP-TLR2 solution at concentra-
tions of 5 ng/μL and 10 ng/μL in volumes of 5 pL. They
were then transferred into the recipients’ oviducts. DNA
was extracted from the ear tissue of each lamb at birth.
To identify transgenic individuals, the following PCR
primers were used: F: 50- TCC AAA ATG TCG TAA
CAA CTC CG - 30; R: 50 - AAA AAG AGA TGT TTCCCC AAG TGT T - 30. The upstream primer was based
on the CMV region and the downstream primer was
based on foreign TLR2. For Southern blotting analysis,
the PCR product of TLR2 was digested with Nhe I and
Hind III (NEB, Beverly, MA, U.S.) and labelled with DIG
(12647521;Roche Diagnostics, Mannheim, Germany) for
use as a probe. Ear tissue section slides were paraffin-
embedded and prepared for immunohistochemical ana-
lysis and TLR2 expression analysis. Anti-goat TLR2-FITC
was used (ab59711; Abcam, Cambridge, U.K.).
Testing of physiological and biochemical parameters
The blood biochemical parameters of transgenic and
control goats were assessed at 120 days. Peripheral blood
was collected and both blood cells serum biochemical para-
meters were assessed. Factors examined here included the
white blood cell count (WBC), red blood cell count (RBC),
and hemoglobin (HGB), hematocrit (HCT), serum total
protein (TP), albumin (Alb), globulin (Glo), alanine amino-
transferase (ALT), aspartate aminotransferase (AST), C-
reactive protein (CRP), glucose (Glu), blood urea nitrogen
(BUN), and triglyceride (TG) levels.
In vitro Pam3CSK4-challenge
Mononuclear cells were isolated from the peripheral
blood of 3 transgenic goats and 3 wild goats by density
gradient centrifugation. Goat lymphocyte separation
medium (TBD, Tianjin, China) was used. Cells were cul-
tured in RPMI 1640 medium (Gibco, Grand Island, NY,
U.S.) supplemented with 10% FBS (Gibco, Grand Island,
NY, USA). For differential adhesion cultures, the
medium was replaced once every 12 hours. During
TLR2 receptor agonist experiments, monocytes and
macrophages were cultured for 48 hours and stimulated
at different times with 1 μg/mL Pam3CSK4 (InvivoGen,
San Diego, CA, U.S.). Cell culture supernatants were
collected, and the concentrations of IFN-γ, IL-10, IL-6,
and LZM were measured using enzyme-linked immuno-
sorbent assay (ELISA) kits. NO and MDA content were
detected using a commercial kit (Jiancheng, Nanjing,
China). All experimental operations were performed
according to kit instructions. Total RNA was extracted
from monocyte-macrophages. Real-time PCR was used
to evaluate TLR2 expression. TLR2- and β-actin-specific
primers were designed (TLR2 F: 50 - TGC TGT GCC
CTC TTC CTG TT - 30, R: 50- GGG ACG AAG TCT
CGC TTA TGA A - 30; β-actin F: 50 - AGA TGT GGA
TCA GCA AGC AG - 30, R: 50 - CCA ATC TCA TCT
CGT TTT CTG - 30). Relative expression was deter-
mined using the comparative 2-△△CT method.
In vivo Pam3CSK4-challenge
Live goats were intradermally injected with 1mg
Pam3CSK4 in the ear. Ear tissues were collected at
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Samples were fixed with 4% paraformaldehyde in
addition to the routine haematoxylin and eosin staining.
Statistical analysis
Individual experiments were repeated three times. All
data were subjected to analysis of variance using the
GLM procedures of the statistical analysis system (SAS
Institute, U.S.). All data are expressed as mean ± SEM.
Differences were considered significant at P< 0.05.
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